+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

From
Metastatic Urothelial Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Urothelial Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
Hepatocellular Carcinoma Drugs Market Report 2025 - Product Thumbnail Image

Hepatocellular Carcinoma Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Thyroid Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Thyroid Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Antibody Drugs: Technologies and Global Markets - Product Thumbnail Image

Antibody Drugs: Technologies and Global Markets

  • Report
  • September 2024
  • 156 Pages
  • Global
From
From
Vaginitis Therapeutics Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Vaginitis Therapeutics Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Cancer Gene Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Gene Therapy - Global Strategic Business Report

  • Report
  • May 2025
  • 194 Pages
  • Global
From
Urinary Tract Infection Treatment Market Report 2025 - Product Thumbnail Image

Urinary Tract Infection Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
Loading Indicator